Conferences

Should Your Patient Be Tested
Your Newly Diagnosed Patient
Managing Your AAT Deficient Patient

Alpha1Health.com Survey

Take our survey to help us best meet the needs of the Alpha-1 community.

Event	Start Date	End Date
CHEST 2008 American College of Chest Physicians Philadelphia, PA	October 25, 2008	October 30, 2008
AARC 2008 54th International Respiratory Congress Anaheim, CA	December 13, 2008	December 16, 2008

To learn about events of interest to Alphas and their families, visit Community Events.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

To view PDF, you will need Adobe® Acrobat® Reader® software.